Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
20 March 2026AI-Driven Design of Antimicrobial Peptide for Combating Resistance and Infectious Diseases
Researchers used artificial intelligence and machine learning to design a novel short antimicrobial peptide, LCN-15, as a potential alternative to traditional antibiotics. The peptide was optimized in silico for effectiveness and safety, showing predicted broad antimicrobial, anti-biofilm, anticancer, antioxidant, and immunomodulatory properties, while also demonstrating low toxicity and good biological stability. By validating their approach […]
Read more... -
19 March 2026Translational Barriers to Phage Endolysin Deployment for Antimicrobial Resistance Control in Africa
Antimicrobial resistance (AMR) is a growing crisis in Africa, worsened by limited diagnostics, uncontrolled antibiotic use, and weak drug development pipelines. Phage-derived endolysins—promising next-generation antimicrobials—offer strong potential due to their rapid action and low risk of resistance, yet their development in Africa remains minimal. This review identifies key barriers preventing progress, including limited scientific capacity, […]
Read more... -
18 March 2026Nanomedicines in the treatment of methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) remains a major global health threat due to its resistance to standard antibiotics and limited treatment options. This review highlights how nanotechnology is emerging as a promising next-generation strategy to overcome these limitations. It outlines several innovative approaches, including metallic nanoparticles that disrupt biofilms and generate reactive oxygen species, advanced materials […]
Read more...
More news related to Smart innovation
